Apollo Hospitals Q3 Results 2025: Profit Jumps, ₹9 Dividend Announced

Apollo Hospitals Q3 results FY25 declared that net profit skyrocketed by 52% in Q3 FY25 to ₹372 crores from ₹245 crores in Q3 FY24. In this blog, we’ll explore all the details of Apollo Hospitals Q3 results and interim dividend declaration.

Apollo Hospitals Q3 Results FY25: Major Highlights

• Revenues grew 14% YoY to ₹5,527 crores in the third quarter of FY25 from ₹4,851 crores in the corresponding quarter of FY24.
• EBITDA grew 24% YoY to ₹762 crores from ₹614 crores in the Q3 FY24.
• In the Apollo Hospitals Q3 results, EBITDA margin expanded to 13.8% versus 12.7% a year ago.
• The healthcare provider is on track to add 3,512 beds over 11 locations in a period spanning 3-4 years, beginning FY26.
• The hospital chain continues to benefit from strong demand for healthcare services, an expanding presence in tier-2 and tier-3 cities, and a growing contribution from its digital health and pharmacy businesses.
• In the last 1-week, Apollo Hospitals share price fell by 6.99% (as on February 11, 2025).

*(in ₹ crores)

Apollo Hospitals Q3 Results: Interim Dividend 

Apollo Hospitals Board has declared an interim dividend of ₹9 per share (180% of the face value of ₹5 per share) for the financial year ending March 31, 2025, rewarding shareholders amid the strong financial performance. 

The record date is set at February 15, 2025 and the payment will be made by February 28, 2025 as per the Apollo Hospitals Q3 results updates. 

Want to invest in the Apollo Hospitals shares? Open Free Demat Account with SMC Global Securities and pick the stocks that match your goals and risk profile. Stay tuned for the latest updates and insightful blogs on Nifty 50 companies quarterly 2025 results. 

Reference:  

SMC Global Securities Research Team

Author: All Content is verified by SMC Global Securities.